CDK2 and breast carcinoma: Therefore, we conclude that CCND1, which belongs to the components of CDK2 and the downstream molecules of HER-2 signaling in Breast Cancer signaling pathway, could promote G1 phase of NIH3T3 by participating in the synthesis and degradation of protein.